• Feedback
  • RSS Feed
  • Sitemap
Ommcom News
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
Odisha News, Odisha Breaking News, Odisha Latest News || Ommcom News
Home Science & Tech

Common Antibiotic Shows Hope For Inflammatory Bowel Disease

OMMCOM NEWS by OMMCOM NEWS
February 11, 2025
in Science & Tech

New Delhi: An antibiotic used to treat infective diarrhoea may be an effective drug for a type of inflammatory bowel disease, according to a new study.

Researchers from the University of Birmingham, UK, showed that an antibiotic called vancomycin may also be effective in treating people who have a specific type of inflammatory bowel disease (IBD), which develops due to an incurable autoimmune liver disease called primary sclerosing cholangitis (PSC).

Notably, four in five patients who participated in the study achieved remission after taking the drug as part of a clinical trial published in the Journal of Crohn’s and Colitis.

The study is significant, as several participants with this disease had not responded to other IBD treatments.

Moreover, IBD and PSC are closely correlated, with most individuals who have PSC developing IBD, and up to 14 per cent of patients with IBD also developing PSC.

Together, the condition raised the need for colon surgery and or developing colon or liver cancer, which would them need a liver transplant. It also raises the overall risk of death.

“Our findings suggest that vancomycin could offer a new therapeutic option for patients with this challenging combination of IBD and autoimmune liver disease,” said Dr. Mohammed Nabil Quraishi from the University of Birmingham.

During the trial, participants were treated with oral antibiotics for four weeks. About 80 per cent of patients achieved clinical remission after the treatment.

They also showed a significant decrease in inflammatory markers, and 100 per cent showed mucosal healing.

However, when the treatment was stopped after 8 weeks, the symptoms returned.

Vancomycin was also shown to induce changes in certain bile acids, which are now being further investigated to develop and refine treatments for IBD-associated PSC.

Although the results are preliminary, they provide a strong foundation for further research, said the team.

(IANS)

ShareTweetSendSharePinShareSend
Previous Post

Two Killed As Speeding Car Hits Auto-Rickshaw In Baripada

Next Post

Gilchrist Disagrees With Ponting, Declares Warne The Greatest Cricketer Ever

Related Posts

Science & Tech

India To Host Global Research Symposium On AI And Its Impact In Feb 2026

October 7, 2025
Science & Tech

WHO Issues New Guidelines To Tackle Deaths From Excessive Bleeding After Childbirth

October 6, 2025
Sridhar Vembu
Odisha

Zoho To Set Up Data Centre In Odisha: Founder Sridhar Vembu

October 2, 2025
Science & Tech

Poor Air Quality May Worsen Sleep Apnoea: Study

September 29, 2025
BSNL 4G
Business

BSNL‘S Indigenous 4G Stack Powers India’s Swadeshi Drive

September 28, 2025
Heart
Science & Tech

Heart Diseases Kill 8 People Every Minute In South-East Asia: WHO

September 27, 2025
Next Post

Gilchrist Disagrees With Ponting, Declares Warne The Greatest Cricketer Ever

India Is Driving Global Growth: PM Modi On India Energy Week

Remuna Tahsildar In Vigilance Net For Possessing Disproportionate Assets

Khimji
OMC
  • Feedback
  • RSS Feed
  • Sitemap

© 2025 - Ommcom News. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

© 2025 - Ommcom News. All Rights Reserved.